Saliva Collection and Diagnosis Market - Growth, Trends, Covid-19 Impact, and Forecasts (2022 - 2027)

The Saliva Collection and Diagnosis Market is projected to register a CAGR of 10% during the forecast period (2022-2027).

Amidst COVID-19, the Saliva collection and diagnosis market is expected to grow owing to the rising cases of infectious disease among the people. The increase in consumer-based DNA testing is projected to create lucrative opportunities for the saliva collection and diagnosis market. The increasing rate of COVID-19 disease spread led to the demand for quick and efficient diagnoses to get the infection treatment. According to World Health Organization (WHO), in 2022, the number of new COVID-19 cases increased by 5% across the globe. The market players took this opportunity to expand their product line and gain a significant market share by providing diagnostic tools. For Instance, In April 2021, Chembio Diagnostics, Inc. announced the launch of an FDA emergency use authorization- approved, in license rapid Point of Care testing (POCT ) for COVID-19 for use in the decentralized and traditional testing settings.

The increasing prevalence of infectious diseases among people across the globe is assumed to be one of the major driving factors for market growth. According to the World Health Organization (WHO), in 2021, 60 % of the global population will be suffering from infectious diseases. Also, the report states that Infectious diseases kill over 17 million people a year, which warns of a global crisis. The rise in the number of infectious cases led to the demand for safe and effective diagnostic systems. Hence, saliva collection and diagnosis play a major role as a non-invasive diagnostic method for screening patients. Also, the increase in the product approvals of saliva collection and diagnostic equipment is also a contributing factor to boosting the market's growth. For Instance, in 2021, Hologic Inc.'s HOLX optima SARS- COV-2 molecular diagnostic test got (Common Era) CE marking by the European Union for its use with a saliva sample.

Therefore increase in the incidence of infectious diseases across the globe led to the increase in demand for saliva collection and diagnosis, resulting in market growth.

Key Market Trends

The Diagnostic Laboratories Segment is Expected to Hold a Major Market Share in the Saliva Collection and Diagnosis Market Market

The sudden outbreak of COVID-19 increased the demand for saliva collection and diagnosis due to the increased infectious cases of COVID-19 disease across the world.

The diagnostic laboratories segment is expected to drive the market's growth due to the increasing usage of saliva collection and diagnosis. Owing to the non-invasive methods of diagnosis, the saliva collection and diagnostic market is expected to grow in the forecast period. Also, the rising prevalence of chronic diseases such as cancer among people led to the increasing usage of non-invasive screening methods in diagnostic laboratories. The Saliva collection and diagnosis is widely used in cancer diagnosis in diagnostic laboratories owing to the accuracy and painless procedure. According to the report published by the National Institute of Health (NIH), in 2020, Saliva tests have over 90% accuracy in detecting oral cancer. In 2022, the American Cancer Society estimated that about 54,00 new cases of the oral cavity or oropharyngeal cancer were in the United States. The increase in such chronic diseases led to an increase in the usage of saliva collection and diagnosis in diagnostic laboratories, which further propels the market's growth.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period.

The United States is likely to command the global market owing to the technological innovations in the diagnostic devices used for disease testing. The increasing prevalence of chronic diseases in the United States contributes to the growing demand for Saliva collection and diagnosis products. According to the National Health Council, in 2020, around 157 million in the United States reported chronic diseases. Moreover, the increase in the growth of the pharmaceutical and biotechnology industry in the region of the united states favors the growth of the saliva collection and diagnosis market. According to the Binder Dijker Otte (BDO) USA Reports, in 2020, companies listed on the biotechnology index (NBI) saw a growth in revenue to 1.049 billion in 2020. Average research and development spending increased by 16% in 2020 to 284.25 million USD in the United States pharmaceutical industry. Thus, the increasing research and development activities in the United States region provide lucrative opportunities for the saliva collection and diagnosis market growth. Also, the presence of major market players along with the skilled personnel to handle the equipment is expected to drive the market growth in this region.

Competitive Landscape

The Saliva Collection and Diagnosis Market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market are Thermo Fisher Scientific, Neogen Corporation, Abbott, Sarstedt AG & Co.KG, Autogen Inc, Oasis Diagnostics, Porex, Salimetrics, LLC, Takara Bio, Inc, Arcis Bio, Orasure Technologies, and others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

This product will be delivered within 2 business days.